Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charis Eng

Showing results (31-40 of 555) with videos related to

Pageof 56
Sort By:
Cell Death Discovery|September 25, 2018
KLLN-mediated DNA damage-induced apoptosis is associated with regulation of p53 phosphorylation and acetylation in breast cancer cellsMadhav Sankunny, Charis Eng
Oncotarget|January 5, 2021
Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cellsMadhav Sankunny, Charis Eng
Thyroid : Official Journal of the American Thyroid Association|February 12, 2020
The "APCs" of PTCs: Adenomatous Polyposis Syndrome and the ThyroidLamis Yehia, Charis Eng
Journal of the National Cancer Institute|February 3, 2016
HABP2 in Familial Non-medullary Thyroid Cancer: Will the Real Mutation Please Stand Up?Joanne Ngeow, Charis Eng
Journal of Surgical Oncology|August 19, 2014
Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndromeJessica Mester, Charis Eng
Personalized Medicine|May 16, 2018
Whole-genome sequencing: not yet making the clinical gradeJoanne Ngeow, Charis Eng
Personalized Medicine|May 20, 2018
Thyroid cancer genetics: how close are we to personalizing clinical management?Joanne Ngeow, Charis Eng
The Journal of Clinical Endocrinology and Metabolism|November 9, 2005
Editorial: germline variants within RET: clinical utility or scientific playtoy?Frank Weber, Charis Eng
BMJ (Clinical Research Ed.)|October 31, 2009
A practical guide to interpretation and clinical application of personal genomic screeningEmily Edelman, Charis Eng
Methods (San Diego, Calif.)|December 3, 2014
PTEN hamartoma tumor syndrome: clinical risk assessment and management protocolJoanne Ngeow, Charis Eng
Pageof 56

Showing results (31-40 of 555) with videos related to

Sort By:
Pageof 56
Cell Death Discovery|September 25, 2018
KLLN-mediated DNA damage-induced apoptosis is associated with regulation of p53 phosphorylation and acetylation in breast cancer cellsMadhav Sankunny, Charis Eng
Oncotarget|January 5, 2021
Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cellsMadhav Sankunny, Charis Eng
Thyroid : Official Journal of the American Thyroid Association|February 12, 2020
The "APCs" of PTCs: Adenomatous Polyposis Syndrome and the ThyroidLamis Yehia, Charis Eng
Journal of the National Cancer Institute|February 3, 2016
HABP2 in Familial Non-medullary Thyroid Cancer: Will the Real Mutation Please Stand Up?Joanne Ngeow, Charis Eng
Journal of Surgical Oncology|August 19, 2014
Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndromeJessica Mester, Charis Eng
Personalized Medicine|May 16, 2018
Whole-genome sequencing: not yet making the clinical gradeJoanne Ngeow, Charis Eng
Personalized Medicine|May 20, 2018
Thyroid cancer genetics: how close are we to personalizing clinical management?Joanne Ngeow, Charis Eng
The Journal of Clinical Endocrinology and Metabolism|November 9, 2005
Editorial: germline variants within RET: clinical utility or scientific playtoy?Frank Weber, Charis Eng
BMJ (Clinical Research Ed.)|October 31, 2009
A practical guide to interpretation and clinical application of personal genomic screeningEmily Edelman, Charis Eng
Methods (San Diego, Calif.)|December 3, 2014
PTEN hamartoma tumor syndrome: clinical risk assessment and management protocolJoanne Ngeow, Charis Eng
Pageof 56